Here, we have demonstrated that downregulation of uPAR not only reduced medulloblastoma cell invasive and migratory capacity but also has the potential to sensitize the tumor for radiation therapy by disrupting the uPAR/integrin/FAK complex essential for cell invasion and migration. The gene discussed is PTK2; the disease is medulloblastoma.